BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29500645)

  • 1. Fractal analysis of contrast-enhanced CT images for preoperative prediction of malignant potential of gastrointestinal stromal tumor.
    Kurata Y; Hayano K; Ohira G; Narushima K; Aoyagi T; Matsubara H
    Abdom Radiol (NY); 2018 Oct; 43(10):2659-2664. PubMed ID: 29500645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
    Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
    Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
    Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of Glucose Metabolism in Esophageal Cancer Measured by Fractal Analysis of Fluorodeoxyglucose Positron Emission Tomography Image: Correlation between Metabolic Heterogeneity and Survival.
    Tochigi T; Shuto K; Kono T; Ohira G; Tohma T; Gunji H; Hayano K; Narushima K; Fujishiro T; Hanaoka T; Akutsu Y; Okazumi S; Matsubara H
    Dig Surg; 2017; 34(3):186-191. PubMed ID: 27931038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Intratumoral Heterogeneity Based on Fractal Geometry Analysis in Operated NSCLC Patients.
    Castello A; Russo C; Grizzi F; Qehajaj D; Lopci E
    Mol Imaging Biol; 2019 Oct; 21(5):965-972. PubMed ID: 30478506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET.
    Narushima K; Shuto K; Okazumi S; Ohira G; Mori M; Hayano K; Yanagawa N; Matsubara H
    Sci Rep; 2023 Feb; 13(1):2266. PubMed ID: 36755154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Structural Heterogeneity Using Fractal Analysis of Contrast-Enhanced CT Image to Predict Survival in Gastric Cancer Patients.
    Watanabe H; Hayano K; Ohira G; Imanishi S; Hanaoka T; Hirata A; Kano M; Matsubara H
    Dig Dis Sci; 2021 Jun; 66(6):2069-2074. PubMed ID: 32691383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
    Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
    World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of preoperative
    Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
    Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors.
    Yoshikawa K; Shimada M; Kurita N; Sato H; Iwata T; Morimoto S; Miyatani T; Kashihara H; Takasu C; Matsumoto N
    Surg Today; 2013 Oct; 43(10):1162-7. PubMed ID: 23143169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index.
    Kwon Y; Park E; Pahk K; Kim S; Kim MJ; Graf D; Park S
    J Cancer Res Ther; 2019; 15(1):142-147. PubMed ID: 30880770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
    J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of FDG-PET stage and uptake for non-small cell lung cancer on non-contrast enhanced CT scans via fractal analysis.
    Al-Kadi OS
    Clin Imaging; 2020 Sep; 65():54-59. PubMed ID: 32361227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.
    Hassanzadeh-Rad A; Yousefifard M; Katal S; Asady H; Fard-Esfahani A; Moghadas Jafari A; Hosseini M
    J Gastroenterol Hepatol; 2016 May; 31(5):929-35. PubMed ID: 26642423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
    Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
    Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors.
    Winant AJ; Gollub MJ; Shia J; Antonescu C; Bains MS; Levine MS
    AJR Am J Roentgenol; 2014 Aug; 203(2):306-14. PubMed ID: 25055264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.